www.bioss.com.cn
400-901-9800
sales@bioss.com.cn
techsupport@bioss.com.cn

Cat. Number:

bs-19029R-HRP

Quantity size:

100ul

Concentration:

1mg/ml  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

NAT-9 is a 207 amino acid protein belonging to the acetyltransferase family and the GNAT subfamily. Containing a N-acetyltransferase domain, NAT-9 may be associated with psoriasis and psoriatic arthritis, a type of inflammatory/autoimmune disease that affects skin, tendons and/or joints of the hands and feet. Expressed as two isoforms produced by alternative splicing events, NAT-9 is encoded by a gene located on human chromosome 17, which comprises over 2.5% of the human genome and encodes over 1,200 genes.

Also known as:

EBSP; Embryo brain specific protein; Embryo brain-specific protein; N-acetyltransferase 9; Nacetyltransferase 9; Nat9; NAT9_HUMAN.

Specificity:

Storage:

0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Application:

Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.